Who led it to failure? Current leadership team. Who led us to the Elanco rejection? Current leadership team. Who continues to over promise and under deliver? Current leadership team.
Who has failed to deliver anything in regards to shareholder returns for years? Current leadership team.
I think you will find this is more the concern rather than the actual loss of epichem.
It can be justified it in a positive light but whether you like it or not, it is yet another symbolic failure by PAA leaders, in a long list of failures big and small.
Ann: MND Biomarkers and Pharmacodynamics Results, page-322
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.8¢ |
Change
0.003(1.52%) |
Mkt cap ! $80.22M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.5¢ | 16.0¢ | $71.27K | 433.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 96696 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 197077 | 8 |
View Market Depth
| Last trade - 12.13pm 08/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |